查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451473

2024-2032 年按组件（软体、服务）、部署类型（本地、基于云端）、最终用户（医院、诊所、门诊服务中心、专科中心等）和区域分類的感染监控解决方案市场报告

Infection Surveillance Solutions Market Report by Component (Software, Services), Deployment Type (On-premises, Cloud-based), End User (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球感染监测解决方案市场规模达到6.526亿美元。展望未来， IMARC Group预计到2032年市场规模将达到13.148亿美元，2024-2032年复合年增长率（CAGR）为7.65%。不断增长的医疗保健相关感染 (HAI)、防止感染传播的严格监管合规性以及允许自动捕获患者资料的医疗保健 IT 的进步是推动该市场的一些主要因素。

感染监测解决方案是医疗机构用来监测和分析患者群体中感染的流行、传播和影响的综合系统。他们利用先进的资料收集、整合和分析工具来追踪和报告各种医疗保健相关感染 (HAI)，例如血流感染、手术部位感染和呼吸道感染。由于它们使医疗保健提供者能够及时识别潜在的疫情、实施有针对性的干预措施并最终提高患者的安全，因此全球范围内对感染监测解决方案的需求正在增加。

目前，对包括感染控制在内的患者安全的日益关注正在促进市场的成长。与此一致的是，人们越来越意识到医疗保健中数据驱动决策的重要性，这正在加强市场的成长。此外，老年人口对感染监测解决方案的需求不断增长，因为他们更容易受到感染，这对市场产生了积极影响。此外，对监测和减轻传染病爆发的监测解决方案的投资不断增加，为行业投资者提供了利润丰厚的成长机会。此外，资料分析、人工智慧 (AI) 和机器学习 (ML) 方面的创新正在增强感染监测解决方案的能力，并使其更加高效，从而支持市场的成长。除此之外，全球医疗保健基础设施的改善正在促进市场的成长。

感染监测解决方案市场趋势/驱动因素：

医疗保健相关感染 (HAI) 不断上升

由于个人中与医疗相关的感染 (HAI) 不断增加，感染监测解决方案的采用率不断上升，推动了市场的成长。与此一致的是，这些感染对患者的健康造成威胁，导致住院时间延长、医疗费用增加，在某些情况下甚至导致死亡。除此之外，减轻这些感染以提高病人安全的需求也在增加。透过持续监测和分析患者资料，这些解决方案能够及早发现感染，并使医疗机构能够及时实施干预措施。因此，医院感染的减少不仅可以改善病患的治疗效果，还可以为医疗机构节省成本。

严格遵守法规以防止感染传播

在医疗保健行业，遵守监管要求和认证标准至关重要。医疗保险和医疗补助服务中心 (CMS) 以及联合委员会等监管机构正在强制报告和预防医疗保健相关感染 (HAI)。此外，不遵守规定可能会导致处罚和声誉损害。除此之外，感染监测解决方案有助于确保合规性。它们有助于准确的资料收集、分析和感染率报告，帮助医疗机构有效满足监管要求。此外，认证机构将感染控制视为医疗保健品质的重要组成部分。此外，医疗保健组织正在投资先进的感染监测系统，这些系统不仅可以满足监管需求，还有助于实现和维持认证，提高其声誉和可信度。

医疗保健 IT 的进步

电子健康记录（EHR）、健康资讯交换（HIE）和综合健康系统的日益普及正在推动市场的成长。据此，感染监测解决方案可以与现有的医疗保健 IT 基础设施无缝连接，并允许自动捕获患者资料、实验室结果和其他相关资讯。这些系统的介面简化了监控过程，并确保了即时资料的可用性以进行分析，这提供了积极的市场前景。医疗保健专业人员可以快速获得可行的见解，有助于及早发现和应对潜在的疫情爆发。此外，这些解决方案和医疗保健 IT 不仅可以增强感染控制，还有助于提高医疗保健服务的整体效率和有效性。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球感染监测解决方案市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按组成部分

  • 软体
    • 市场走向
    • 市场预测
  • 服务
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依部署类型

  • 本地
    • 市场走向
    • 市场预测
  • 基于云端
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 流动服务中心
    • 市场走向
    • 市场预测
  • 专科中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Centrak Inc. (Halma plc)
    • Cerner Corporation
    • CKM Healthcare Incorporated
    • Ecolab Inc.
    • International Business Machines Corporation
    • Medexter Healthcare
    • Perahealth Inc.
    • PointClickCare
    • Premier Inc.
    • Sunquest Information Systems Inc. (Roper Technologies Inc.)
Product Code: SR112024A4857

The global infection surveillance solutions market size reached US$ 652.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,314.8 Million by 2032, exhibiting a growth rate (CAGR) of 7.65% during 2024-2032. The growing healthcare-associated infections (HAIs), stringent regulatory compliance for preventing the spread of infection, and advancements in healthcare IT that allow for the automatic capture of patient data are some of the major factors propelling the market.

Infection surveillance solutions are comprehensive systems that are employed by healthcare facilities to monitor and analyze the prevalence, spread, and impact of infections within their patient populations. They utilize advanced data collection, integration, and analysis tools to track and report on various healthcare-associated infections (HAIs), such as bloodstream infections, surgical site infections, and respiratory infections. As they enable healthcare providers to promptly identify potential outbreaks, implement targeted interventions, and ultimately enhance patient safety, the demand for infection surveillance solutions is increasing worldwide.

At present, the rising focus on patient safety, which includes infection control, is contributing to the growth of the market. In line with this, the increasing awareness about the importance of data-driven decision-making in healthcare is strengthening the growth of the market. Moreover, the growing demand for infection surveillance solutions among the geriatric population, as they are more vulnerable to infections, is positively influencing the market. In addition, rising investments in surveillance solutions to monitor and mitigate infectious disease outbreaks is offering lucrative growth opportunities to industry investors. Furthermore, innovations in data analytics, artificial intelligence (AI), and machine learning (ML) are enhancing the capabilities of infection surveillance solutions and making them more efficient is supporting the growth of the market. Besides this, the improving healthcare infrastructure facilities across the globe is bolstering the growth of the market.

Infection Surveillance Solutions Market Trends/Drivers:

Rising healthcare-associated infections (HAIs)

The rising adoption of infection surveillance solutions due to the increasing healthcare-associated Infections (HAIs) among individuals is contributing to the growth of the market. In line with this, these infections cause threats to patient well-being that lead to extended hospital stays, increased healthcare costs, and, in some cases, mortality. Apart from this, there is a rise in the need to mitigate these infections to enhance patient safety. By continuously monitoring and analyzing patient data, these solutions enable early detection of infections and allow healthcare facilities to implement timely interventions. Consequently, the reduction in HAIs not only improves patient outcomes but also leads to cost savings for healthcare organizations.

Stringent regulatory compliance for preventing spread of infection

In the healthcare industry, compliance with regulatory requirements and accreditation standards is vital. Regulatory bodies, such as the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission are mandating the reporting and prevention of healthcare-associated infections (HAIs). In addition, failure to comply can result in penalties and reputational damage. Besides this, infection surveillance solutions are instrumental in ensuring compliance. They facilitate accurate data collection, analysis, and reporting of infection rates, helping healthcare facilities meet regulatory demands efficiently. Additionally, accreditation bodies focus on infection control as a critical component of healthcare quality. Furthermore, healthcare organizations are investing in advanced infection surveillance systems that not only satisfy regulatory needs but also contribute to achieving and maintaining accreditation, enhancing their reputation and trustworthiness.

Advancements in healthcare IT

The increasing adoption of electronic health records (EHRs), health information exchange (HIE), and integrated health systems is bolstering the growth of the market. In line with this, infection surveillance solutions can seamlessly interface with existing healthcare IT infrastructure and allow for the automatic capture of patient data, laboratory results, and other pertinent information. The interface of these systems streamlines the surveillance process and ensures the availability of real-time data for analysis, which is offering a positive market outlook. Healthcare professionals can access actionable insights quickly that aid in early detection and response to potential outbreaks. Moreover, these solutions and healthcare IT not only enhance infection control but also contribute to the overall efficiency and effectiveness of healthcare delivery.

Infection Surveillance Solutions Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on component, deployment type, and end user.

Breakup by Component:

Software

Services

Software represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the component. This includes software and services. According to the report, software represented the largest segment. The software is responsible for the collection, integration, analysis, and presentation of data related to healthcare-associated infections (HAIs) and infectious diseases. It plays a vital role in transforming raw patient data into actionable insights for healthcare providers. It comprises numerous functionalities, such as data integration, real-time monitoring, data analysis, reporting and visualization, and compliance and regulatory support. In line with this, the software enables healthcare organizations to proactively manage infections, improve patient safety, and enhance overall healthcare quality, which is contributing to the growth of the market.

Breakup by Deployment Type:

On-premises

Cloud-based

On-premises accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the deployment type. This includes on-premises and cloud-based. According to the report, on-premises represented the largest segment. On-premises refers to the installation and operation of infection surveillance solutions within the physical infrastructure of a healthcare facility or organization. In this deployment model, all software, hardware, and data storage are maintained locally on-site. On-premises solutions can be customized to meet the specific needs and workflows of the organization and allow for tailored infection surveillance processes. Apart from this, it offers low-latency access to information that allows for real-time monitoring and response to infection trends. Organizations often choose this deployment model when they prioritize data control, security, and compliance while accepting the responsibility of managing their IT infrastructure.

Breakup by End User:

Hospitals

Clinics

Ambulatory Service Centers

Specialty Centers

Others

Hospitals hold the biggest market share

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, clinics, ambulatory service centers, specialty centers, and others. According to the report, hospitals represented the largest segment. Hospitals are characterized by their high patient volumes, complex care environments, and the critical need for infection control. Moreover, hospitals prioritize patient safety, and infection surveillance is fundamental in achieving this goal. These solutions enable hospitals to monitor, detect, and prevent healthcare-associated infections (HAIs) promptly, thereby reducing patient morbidity and mortality. In addition, efficient infection control helps hospitals optimize resource allocation. By identifying infection trends and risk factors, hospitals can allocate resources effectively and ensure that critical care units and staff are available where needed most.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection surveillance solutions market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the presence of advanced healthcare infrastructure. Apart from this, the rising focus on healthcare quality and patient safety is contributing to the growth of the market in the region. In line with this, stringent regulatory requirements in North America are necessitating the implementation of comprehensive infection surveillance solutions, which is propelling the growth of the market. Besides this, the rising demand for solutions that have real-time data and analytics capabilities is bolstering the growth of the market in the North America region.

Competitive Landscape:

Key manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. Apart from this, solution providers are enhancing their data encryption, access controls, and compliance features to meet stringent healthcare regulations due to the increasing focus on data security and privacy. Furthermore, major players are offering cloud-based solutions to provide scalability, flexibility, and easier access to real-time data.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Baxter International Inc.

Becton Dickinson and Company

Centrak Inc. (Halma plc)

Cerner Corporation

CKM Healthcare Incorporated

Ecolab Inc.

International Business Machines Corporation

Medexter Healthcare

Perahealth Inc.

PointClickCare

Premier Inc.

Sunquest Information Systems Inc. (Roper Technologies Inc.)

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In January 2022, BD (Becton, Dickinson and Company), a leading global medical technology company, collaborated with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.

In 2021, Ecolab, the global leader in water, hygiene and infection prevention solutions and services, launched its Hand Hygiene Compliance Measurement (HHCM) System, a digitally connected technology to systematically monitor and improve hand hygiene in healthcare settings, across Europe.

In June 2022, Premier, Inc. announced that it is extending its technological capabilities to long-term care (LTC) facilities and providing the same level of clinical surveillance used in the acute setting.

Key Questions Answered in This Report

  • 1. What was the size of the global infection surveillance solutions market in 2023?
  • 2. What is the expected growth rate of the global infection surveillance solutions market during 2024-2032?
  • 3. What are the key factors driving the global infection surveillance solutions market?
  • 4. What has been the impact of COVID-19 on the global infection surveillance solutions market?
  • 5. What is the breakup of the global infection surveillance solutions market based on the component?
  • 6. What is the breakup of the global infection surveillance solutions market based on the deployment type?
  • 7. What is the breakup of the global infection surveillance solutions market based on the end user?
  • 8. What are the key regions in the global infection surveillance solutions market?
  • 9. Who are the key players/companies in the global infection surveillance solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Surveillance Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Deployment Type

  • 7.1 On-premises
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloud-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Service Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Specialty Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Centrak Inc. (Halma plc)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Cerner Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 CKM Healthcare Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ecolab Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 International Business Machines Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medexter Healthcare
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Perahealth Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 PointClickCare
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Premier Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sunquest Information Systems Inc. (Roper Technologies Inc.)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Infection Surveillance Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Infection Surveillance Solutions Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Infection Surveillance Solutions Market: Breakup by Deployment Type (in %), 2023
  • Figure 6: Global: Infection Surveillance Solutions Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Infection Surveillance Solutions Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Infection Surveillance Solutions (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Infection Surveillance Solutions (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Infection Surveillance Solutions (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Infection Surveillance Solutions (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Infection Surveillance Solutions (On-premises) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Infection Surveillance Solutions (On-premises) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Infection Surveillance Solutions (Cloud-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Infection Surveillance Solutions (Cloud-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Infection Surveillance Solutions (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Infection Surveillance Solutions (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Infection Surveillance Solutions (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Infection Surveillance Solutions (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Infection Surveillance Solutions (Specialty Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Infection Surveillance Solutions (Specialty Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Infection Surveillance Solutions (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Infection Surveillance Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Infection Surveillance Solutions Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Infection Surveillance Solutions Industry: SWOT Analysis
  • Figure 76: Global: Infection Surveillance Solutions Industry: Value Chain Analysis
  • Figure 77: Global: Infection Surveillance Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Surveillance Solutions Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Infection Surveillance Solutions Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Infection Surveillance Solutions Market Forecast: Breakup by Deployment Type (in Million US$), 2024-2032
  • Table 4: Global: Infection Surveillance Solutions Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Infection Surveillance Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Infection Surveillance Solutions Market: Competitive Structure
  • Table 7: Global: Infection Surveillance Solutions Market: Key Players